4.7 Article

Potent and Selective Fluoroketone Inhibitors of Group VIA Calcium-Independent Phospholipase A2

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 53, Issue 9, Pages 3602-3610

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm901872v

Keywords

-

Funding

  1. European Social Fund
  2. National Resources
  3. NIH [GM 20,501]

Ask authors/readers for more resources

Group VIA calcium-independent phospholipase A(2) (GVIA 1PLA(2)) has recently emerged as a novel pharmaceutical target. We have now explored the structure activity relationship between fluoroketones and GVIA iPLA(2) inhibition. The presence of a naphthyl group proved to be of paramount importance, 1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one (FKGK18) is the most potent inhibitor of GVIA iPLA(2) (X-1(50) = 0.0002) ever reported. Being 195 and >455 times more potent for GVIA iPLA(2) than for GIVA cPLA(2) and GV sPLA(2), respectively, makes it a valuable tool to explore the role of GVIA iPLA(2) in cells and in vivo models. 1,1,1,2,2,3,3-Heptafluoro-8-(naphthalene-2-yl)octan-4-one inhibited GVIA iPLA(2) with a X-1(50) value of 0.001 while inhibiting the other intracellular GIVA cPLA(2) and GV sPLA(2) at least 90 times less potently. Hexa- and octafluoro ketones were also found to be potent inhibitors of GVIA iPLA(2); however, they are not selective.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available